Combined Functional Genome Survey of Therapeutic Targets for Clear Cell Carcinoma of the Kidney
Objective Emerging molecular targeting therapeutics have been incorporated into the management of advanced renal cell carcinoma; however, their efficacy remains limited. The aim of this study was to catalog potential therapeutic target molecules for renal cell carcinoma. Methods We first selected ge...
Gespeichert in:
| Veröffentlicht in: | Japanese journal of clinical oncology 2011-07, Vol.41 (7), p.847-853 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 853 |
|---|---|
| container_issue | 7 |
| container_start_page | 847 |
| container_title | Japanese journal of clinical oncology |
| container_volume | 41 |
| creator | Ito, Hideaki Honda, Kazufumi Satow, Reiko Arai, Eri Shitashige, Miki Ono, Masaya Sakuma, Tomohiro Sakano, Shigeru Naito, Katsusuke Matsuyama, Hideyasu Yamada, Tesshi |
| description | Objective
Emerging molecular targeting therapeutics have been incorporated into the management of advanced renal cell carcinoma; however, their efficacy remains limited. The aim of this study was to catalog potential therapeutic target molecules for renal cell carcinoma.
Methods
We first selected genes up-regulated in clear cell renal cell carcinoma relative to surrounding normal kidney tissues in 10 patients (Study Cohort) using high-density exon arrays that detect all potential transcripts predicted in the human genome. The selected genes were subjected to independent validation in another set of 10 patients (Validation Cohort) using real-time reverse transcriptase polymerase chain reaction and functional screening using small interfering RNA in six clear cell renal cell carcinoma cell lines.
Results
We identified 164 genes whose expression was significantly elevated in clear cell renal cell carcinoma (P< 0.0001 [Student's t-test] and at least a 3-fold change in transcription signal). We finally extracted 33 genes required for maintaining cell proliferation in at least two clear cell renal cell carcinoma cell lines. The 33 genes included 13 genes known to be associated with the development/progression of renal cell carcinoma, including CAIX and FLT-1, confirming the robustness of the current strategy.
Conclusions
Through a combination of genome-wide expression and functional assays, we identified a set of genes with high potential as targets for drug development. This method is rapid and comprehensive and could be applied to the discovery of diagnostic biomarkers and therapeutic targets for cancers other than clear cell renal cell carcinoma. |
| doi_str_mv | 10.1093/jjco/hyr060 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_874481830</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/jjco/hyr060</oup_id><sourcerecordid>1753507554</sourcerecordid><originalsourceid>FETCH-LOGICAL-c479t-c02397687fa7ee76a3ea2ad44deb9493c28802ccbf74fabbc888ac91741a47b53</originalsourceid><addsrcrecordid>eNp90MFLwzAUBvAgipvTk3fJSQWpS5qkSY9S3BQHHpznkqavrqNtZtIK_e_t6PS4y3uX3_t4fAhdU_JISczm262x803vSERO0JTySAQsCukpmhIWqSBUlE7QhfdbQohQXJ6jSUiFjCjlU5Qmts7KBnK86BrTlrbRFV5CY2vAH537gR7bAq834PQOurY0eK3dF7QeF9bhpAI9TKgqnGhnyuFM7327AfxW5g30l-is0JWHq8Oeoc_F8zp5CVbvy9fkaRUYLuM2MCRksYyULLQEkJFmoEOdc55DFvOYmVApEhqTFZIXOsuMUkqbmEpONZeZYDN0N-bunP3uwLdpXXozPKYbsJ1PleRcUcXIIO-PSioFE0QKwQf6MFLjrPcOinTnylq7PqUk3Xef7rtPx-4HfXMI7rIa8n_7V_YAbkdgu93RpF8Jso3b</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1753507554</pqid></control><display><type>article</type><title>Combined Functional Genome Survey of Therapeutic Targets for Clear Cell Carcinoma of the Kidney</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Ito, Hideaki ; Honda, Kazufumi ; Satow, Reiko ; Arai, Eri ; Shitashige, Miki ; Ono, Masaya ; Sakuma, Tomohiro ; Sakano, Shigeru ; Naito, Katsusuke ; Matsuyama, Hideyasu ; Yamada, Tesshi</creator><creatorcontrib>Ito, Hideaki ; Honda, Kazufumi ; Satow, Reiko ; Arai, Eri ; Shitashige, Miki ; Ono, Masaya ; Sakuma, Tomohiro ; Sakano, Shigeru ; Naito, Katsusuke ; Matsuyama, Hideyasu ; Yamada, Tesshi</creatorcontrib><description>Objective
Emerging molecular targeting therapeutics have been incorporated into the management of advanced renal cell carcinoma; however, their efficacy remains limited. The aim of this study was to catalog potential therapeutic target molecules for renal cell carcinoma.
Methods
We first selected genes up-regulated in clear cell renal cell carcinoma relative to surrounding normal kidney tissues in 10 patients (Study Cohort) using high-density exon arrays that detect all potential transcripts predicted in the human genome. The selected genes were subjected to independent validation in another set of 10 patients (Validation Cohort) using real-time reverse transcriptase polymerase chain reaction and functional screening using small interfering RNA in six clear cell renal cell carcinoma cell lines.
Results
We identified 164 genes whose expression was significantly elevated in clear cell renal cell carcinoma (P< 0.0001 [Student's t-test] and at least a 3-fold change in transcription signal). We finally extracted 33 genes required for maintaining cell proliferation in at least two clear cell renal cell carcinoma cell lines. The 33 genes included 13 genes known to be associated with the development/progression of renal cell carcinoma, including CAIX and FLT-1, confirming the robustness of the current strategy.
Conclusions
Through a combination of genome-wide expression and functional assays, we identified a set of genes with high potential as targets for drug development. This method is rapid and comprehensive and could be applied to the discovery of diagnostic biomarkers and therapeutic targets for cancers other than clear cell renal cell carcinoma.</description><identifier>ISSN: 0368-2811</identifier><identifier>EISSN: 1465-3621</identifier><identifier>DOI: 10.1093/jjco/hyr060</identifier><identifier>PMID: 21576114</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Adenocarcinoma, Clear Cell - drug therapy ; Adenocarcinoma, Clear Cell - genetics ; Adenocarcinoma, Clear Cell - pathology ; Adult ; Aged ; Biomarkers, Tumor - genetics ; Cell Line, Tumor ; Cell Proliferation ; Exons ; Female ; Gene Expression Regulation, Neoplastic ; Genome, Human - genetics ; Genome-Wide Association Study ; Humans ; Kidney Neoplasms - drug therapy ; Kidney Neoplasms - genetics ; Kidney Neoplasms - pathology ; Male ; Middle Aged ; Molecular Targeted Therapy ; Neoplasm Staging ; Reproducibility of Results ; Reverse Transcriptase Polymerase Chain Reaction ; RNA, Small Interfering - analysis ; Transcription, Genetic ; Up-Regulation</subject><ispartof>Japanese journal of clinical oncology, 2011-07, Vol.41 (7), p.847-853</ispartof><rights>The Author (2011). Published by Oxford University Press. All rights reserved 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c479t-c02397687fa7ee76a3ea2ad44deb9493c28802ccbf74fabbc888ac91741a47b53</citedby><cites>FETCH-LOGICAL-c479t-c02397687fa7ee76a3ea2ad44deb9493c28802ccbf74fabbc888ac91741a47b53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1578,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21576114$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ito, Hideaki</creatorcontrib><creatorcontrib>Honda, Kazufumi</creatorcontrib><creatorcontrib>Satow, Reiko</creatorcontrib><creatorcontrib>Arai, Eri</creatorcontrib><creatorcontrib>Shitashige, Miki</creatorcontrib><creatorcontrib>Ono, Masaya</creatorcontrib><creatorcontrib>Sakuma, Tomohiro</creatorcontrib><creatorcontrib>Sakano, Shigeru</creatorcontrib><creatorcontrib>Naito, Katsusuke</creatorcontrib><creatorcontrib>Matsuyama, Hideyasu</creatorcontrib><creatorcontrib>Yamada, Tesshi</creatorcontrib><title>Combined Functional Genome Survey of Therapeutic Targets for Clear Cell Carcinoma of the Kidney</title><title>Japanese journal of clinical oncology</title><addtitle>Jpn J Clin Oncol</addtitle><description>Objective
Emerging molecular targeting therapeutics have been incorporated into the management of advanced renal cell carcinoma; however, their efficacy remains limited. The aim of this study was to catalog potential therapeutic target molecules for renal cell carcinoma.
Methods
We first selected genes up-regulated in clear cell renal cell carcinoma relative to surrounding normal kidney tissues in 10 patients (Study Cohort) using high-density exon arrays that detect all potential transcripts predicted in the human genome. The selected genes were subjected to independent validation in another set of 10 patients (Validation Cohort) using real-time reverse transcriptase polymerase chain reaction and functional screening using small interfering RNA in six clear cell renal cell carcinoma cell lines.
Results
We identified 164 genes whose expression was significantly elevated in clear cell renal cell carcinoma (P< 0.0001 [Student's t-test] and at least a 3-fold change in transcription signal). We finally extracted 33 genes required for maintaining cell proliferation in at least two clear cell renal cell carcinoma cell lines. The 33 genes included 13 genes known to be associated with the development/progression of renal cell carcinoma, including CAIX and FLT-1, confirming the robustness of the current strategy.
Conclusions
Through a combination of genome-wide expression and functional assays, we identified a set of genes with high potential as targets for drug development. This method is rapid and comprehensive and could be applied to the discovery of diagnostic biomarkers and therapeutic targets for cancers other than clear cell renal cell carcinoma.</description><subject>Adenocarcinoma, Clear Cell - drug therapy</subject><subject>Adenocarcinoma, Clear Cell - genetics</subject><subject>Adenocarcinoma, Clear Cell - pathology</subject><subject>Adult</subject><subject>Aged</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation</subject><subject>Exons</subject><subject>Female</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Genome, Human - genetics</subject><subject>Genome-Wide Association Study</subject><subject>Humans</subject><subject>Kidney Neoplasms - drug therapy</subject><subject>Kidney Neoplasms - genetics</subject><subject>Kidney Neoplasms - pathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Molecular Targeted Therapy</subject><subject>Neoplasm Staging</subject><subject>Reproducibility of Results</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA, Small Interfering - analysis</subject><subject>Transcription, Genetic</subject><subject>Up-Regulation</subject><issn>0368-2811</issn><issn>1465-3621</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90MFLwzAUBvAgipvTk3fJSQWpS5qkSY9S3BQHHpznkqavrqNtZtIK_e_t6PS4y3uX3_t4fAhdU_JISczm262x803vSERO0JTySAQsCukpmhIWqSBUlE7QhfdbQohQXJ6jSUiFjCjlU5Qmts7KBnK86BrTlrbRFV5CY2vAH537gR7bAq834PQOurY0eK3dF7QeF9bhpAI9TKgqnGhnyuFM7327AfxW5g30l-is0JWHq8Oeoc_F8zp5CVbvy9fkaRUYLuM2MCRksYyULLQEkJFmoEOdc55DFvOYmVApEhqTFZIXOsuMUkqbmEpONZeZYDN0N-bunP3uwLdpXXozPKYbsJ1PleRcUcXIIO-PSioFE0QKwQf6MFLjrPcOinTnylq7PqUk3Xef7rtPx-4HfXMI7rIa8n_7V_YAbkdgu93RpF8Jso3b</recordid><startdate>20110701</startdate><enddate>20110701</enddate><creator>Ito, Hideaki</creator><creator>Honda, Kazufumi</creator><creator>Satow, Reiko</creator><creator>Arai, Eri</creator><creator>Shitashige, Miki</creator><creator>Ono, Masaya</creator><creator>Sakuma, Tomohiro</creator><creator>Sakano, Shigeru</creator><creator>Naito, Katsusuke</creator><creator>Matsuyama, Hideyasu</creator><creator>Yamada, Tesshi</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20110701</creationdate><title>Combined Functional Genome Survey of Therapeutic Targets for Clear Cell Carcinoma of the Kidney</title><author>Ito, Hideaki ; Honda, Kazufumi ; Satow, Reiko ; Arai, Eri ; Shitashige, Miki ; Ono, Masaya ; Sakuma, Tomohiro ; Sakano, Shigeru ; Naito, Katsusuke ; Matsuyama, Hideyasu ; Yamada, Tesshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c479t-c02397687fa7ee76a3ea2ad44deb9493c28802ccbf74fabbc888ac91741a47b53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adenocarcinoma, Clear Cell - drug therapy</topic><topic>Adenocarcinoma, Clear Cell - genetics</topic><topic>Adenocarcinoma, Clear Cell - pathology</topic><topic>Adult</topic><topic>Aged</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation</topic><topic>Exons</topic><topic>Female</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Genome, Human - genetics</topic><topic>Genome-Wide Association Study</topic><topic>Humans</topic><topic>Kidney Neoplasms - drug therapy</topic><topic>Kidney Neoplasms - genetics</topic><topic>Kidney Neoplasms - pathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Molecular Targeted Therapy</topic><topic>Neoplasm Staging</topic><topic>Reproducibility of Results</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA, Small Interfering - analysis</topic><topic>Transcription, Genetic</topic><topic>Up-Regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ito, Hideaki</creatorcontrib><creatorcontrib>Honda, Kazufumi</creatorcontrib><creatorcontrib>Satow, Reiko</creatorcontrib><creatorcontrib>Arai, Eri</creatorcontrib><creatorcontrib>Shitashige, Miki</creatorcontrib><creatorcontrib>Ono, Masaya</creatorcontrib><creatorcontrib>Sakuma, Tomohiro</creatorcontrib><creatorcontrib>Sakano, Shigeru</creatorcontrib><creatorcontrib>Naito, Katsusuke</creatorcontrib><creatorcontrib>Matsuyama, Hideyasu</creatorcontrib><creatorcontrib>Yamada, Tesshi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Japanese journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ito, Hideaki</au><au>Honda, Kazufumi</au><au>Satow, Reiko</au><au>Arai, Eri</au><au>Shitashige, Miki</au><au>Ono, Masaya</au><au>Sakuma, Tomohiro</au><au>Sakano, Shigeru</au><au>Naito, Katsusuke</au><au>Matsuyama, Hideyasu</au><au>Yamada, Tesshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combined Functional Genome Survey of Therapeutic Targets for Clear Cell Carcinoma of the Kidney</atitle><jtitle>Japanese journal of clinical oncology</jtitle><addtitle>Jpn J Clin Oncol</addtitle><date>2011-07-01</date><risdate>2011</risdate><volume>41</volume><issue>7</issue><spage>847</spage><epage>853</epage><pages>847-853</pages><issn>0368-2811</issn><eissn>1465-3621</eissn><abstract>Objective
Emerging molecular targeting therapeutics have been incorporated into the management of advanced renal cell carcinoma; however, their efficacy remains limited. The aim of this study was to catalog potential therapeutic target molecules for renal cell carcinoma.
Methods
We first selected genes up-regulated in clear cell renal cell carcinoma relative to surrounding normal kidney tissues in 10 patients (Study Cohort) using high-density exon arrays that detect all potential transcripts predicted in the human genome. The selected genes were subjected to independent validation in another set of 10 patients (Validation Cohort) using real-time reverse transcriptase polymerase chain reaction and functional screening using small interfering RNA in six clear cell renal cell carcinoma cell lines.
Results
We identified 164 genes whose expression was significantly elevated in clear cell renal cell carcinoma (P< 0.0001 [Student's t-test] and at least a 3-fold change in transcription signal). We finally extracted 33 genes required for maintaining cell proliferation in at least two clear cell renal cell carcinoma cell lines. The 33 genes included 13 genes known to be associated with the development/progression of renal cell carcinoma, including CAIX and FLT-1, confirming the robustness of the current strategy.
Conclusions
Through a combination of genome-wide expression and functional assays, we identified a set of genes with high potential as targets for drug development. This method is rapid and comprehensive and could be applied to the discovery of diagnostic biomarkers and therapeutic targets for cancers other than clear cell renal cell carcinoma.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>21576114</pmid><doi>10.1093/jjco/hyr060</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0368-2811 |
| ispartof | Japanese journal of clinical oncology, 2011-07, Vol.41 (7), p.847-853 |
| issn | 0368-2811 1465-3621 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_874481830 |
| source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Adenocarcinoma, Clear Cell - drug therapy Adenocarcinoma, Clear Cell - genetics Adenocarcinoma, Clear Cell - pathology Adult Aged Biomarkers, Tumor - genetics Cell Line, Tumor Cell Proliferation Exons Female Gene Expression Regulation, Neoplastic Genome, Human - genetics Genome-Wide Association Study Humans Kidney Neoplasms - drug therapy Kidney Neoplasms - genetics Kidney Neoplasms - pathology Male Middle Aged Molecular Targeted Therapy Neoplasm Staging Reproducibility of Results Reverse Transcriptase Polymerase Chain Reaction RNA, Small Interfering - analysis Transcription, Genetic Up-Regulation |
| title | Combined Functional Genome Survey of Therapeutic Targets for Clear Cell Carcinoma of the Kidney |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T18%3A40%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combined%20Functional%20Genome%20Survey%20of%20Therapeutic%20Targets%20for%20Clear%20Cell%20Carcinoma%20of%20the%20Kidney&rft.jtitle=Japanese%20journal%20of%20clinical%20oncology&rft.au=Ito,%20Hideaki&rft.date=2011-07-01&rft.volume=41&rft.issue=7&rft.spage=847&rft.epage=853&rft.pages=847-853&rft.issn=0368-2811&rft.eissn=1465-3621&rft_id=info:doi/10.1093/jjco/hyr060&rft_dat=%3Cproquest_cross%3E1753507554%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1753507554&rft_id=info:pmid/21576114&rft_oup_id=10.1093/jjco/hyr060&rfr_iscdi=true |